Clinical Characteristics and Predictors of Mortality in Minority Patients Hospitalized with COVID-19 Infection

Abstract

Objectives To identify the early mortality predictors in minority patients hospitalized with coronavirus disease 2019 . Design Demographics, presenting characteristics, admission laboratory data, ICU admission, and mortality data were collected from 200 consecutively hospitalized patients with COVID-19. Results The mean (SD) age was 58.9 (15.1) years, 121(60.5%) were men, 143 (71.5%) were African Americans, and 33 (16.5%) were Latino. Common presenting symptoms were cough 130 (65.0%), shortness of breath 129 (64.5%), and fever 121 (60.5%). One or more comorbid illness occurred in 171 (85.5%) and common comorbidities were hypertension (130 (65.2%)), diabetes (100 (50.0%)) and chronic kidney disease (60 (30.0%)). Of the 200 patients, 71 (35.5%) were treated in the ICU, 47 (24.2%) received mechanical ventilation, 45 (22.5%) died, and 155(77.5%) patients discharged home alive. The non-survivors were significantly older and had elevated markers of inflammation, coagulation, and acute organ damage on presentation. Age ≥ 65 years (odds ratio (

C-Reactive Protein Level Predicts Need For Medical Intervention In Pregnant Women With SARS-CoV2 Infection: A Retrospective Study

“…Among the laboratory indices measured, high CRP level and high platelet number were signi cant factors associated with the need for medical intervention (Tables 2 and 3). This is consistent with previous reports in the general population [6,7]. In particular, CRP level days 4-6 after onset had a high sensitivity and speci city for the selection of subjects who needed treatment intervention.…”

Impact of asthma on COVID-19 mortality in the United States: Evidence based on a meta-analysis

“…After evaluating and assessing as much as 257 potential studies, 201 studies were removed due to outcome of interest being not available. In the end, what underlay this meta-analysis were eligible fifty-six articles with 426,261 COVID-19 patients [5] , [6] , [7] , [8] , [9] , [16] , [17] , [18] , [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] , [32] , [33] , [34] , [35] , [36] , [37] , [38] , [39] , [40] , [41] , [42] , [43] , [44] , [45] , [46] , [47] , [48] , [49] , [50] , [51] , [52] , [53] , [54] , [55] , [56] , [57] , [58] , [59] , [60] , [61] , [62] , [63] , [64] , [65] , [66] . The detail of selection process is shown by a chart flow in Figure 1 .…”

C‐reactive protein level predicts need for medical intervention in pregnant women with SARS‐CoV2 infection: A retrospective study

“…This study identi ed early clinical factors that predict disease progression in pregnant subjects infected with SARS-CoV2 who required admission to the hospital for therapeutic intervention. To date, several laboratory ndings have been reported as being associated with worse outcomes in nonpregnant subjects infected with SARS-CoV2 [5][6][7]. However, to the best of our knowledge, this is the rst report showing laboratory measurements associated with the need for therapeutic intervention in pregnant women.…”